REVIEW PAPER
Colorectal cancer in the course of familial adenomatous polyposis:
natural history and treatment methods
1
Department of Surgical Medicine with the Laboratory of Medical Genetics, Institute of Medical Sciences, Jan Kochanowski University, Kielce, Poland
2
Department of Clinic General Oncological and Endocrinological Surgery, Regional Hospital, Kielce, Poland
3
Department of Surgical Oncology, Holy Cross Cancer Center, Kielce, Poland
4
Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Submission date: 2018-04-19
Final revision date: 2020-10-24
Acceptance date: 2020-10-25
Publication date: 2020-12-31
Medical Studies 2020;36(4):303-309
KEYWORDS
TOPICS
ABSTRACT
Familial adenomatous polyposis (FAP) is a group of diseases, mostly caused by an APC suppressor gene mutation inherited in an autosomal dominant pattern. It results in numerous adenomas formed in the epithelium of the large intestine leading to colorectal cancer in 100% of cases, with the mean age of 39, and a high risk of other fatal neoplasms. There is no causative treatment possible. Total colectomy performed at the right time is the only way to prevent the individual from developing colorectal cancer. The aim of this study was to present the diagnostic performance and treatment methods of FAP. Fast diagnosis and strict surveillance of patients and their families are the most important for effective treatment.
REFERENCES (43)
1.
Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, Chun SH, Han HJ, Park JG. Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 1999; 44: 103-108.
3.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-932.
4.
Bülow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967. Dis Colon Rectum 1980; 23: 327-336.
5.
Burdyński R. Odmienności przebiegu pooperacyjnego chorych po proktokolektomii odtwórczej z powodu wrzodziejącego zapalenia jelita grubego i polipowatości rodzinnej. Doctoral thesiss. Published online 2011. http://www.wbc.poznan.pl/Conte....
6.
Truta B, Allen BA, Conrad PG, Weinberg V, Miller GA, Pomponio R, Lipton LR, Guerra G, Tomlinson IPM, Sleisenger MH, Kim YS, Terdiman JP. A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history. Fam Cancer 2005; 4: 127-133.
7.
Narayan S, Roy D. Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer 2003; 2: 41-41.
8.
Pławski A, Podralska M, Krokowicz P, Paszkowski J, Lubiński J, Słomski R. Rodzinna polipowatość gruczolakowata jelita grubego. Postępy Nauk Med 2008; 7: 463-471.
9.
Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3: 121-125.
10.
Heinimann K, Müllhaupt B, Weber W, Attenhofer M, Scott R, Fried M, Martinoli S, Muller H, Dobbie Z. Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 1998; 43: 675-679.
11.
Rustin RB, Jagelman DG, McGannon E, Fazio VW, Lavery IC, Weakley FL. Spontaneous mutation in familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 52-55.
12.
Harb WJ. Gastrointestinal Polyposis Syndromes. In: Inherited Cancer Syndromes: Current Clinical Management. Ellis CN (eds.). Springer New York 2011; 105-125.
13.
Vasen HFA, Möslein G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bülow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Järvinen H, Mecklin JP, Møller P, Myrhøi T, Nagengast FM, Parc Y, Phillips R, Clark SK, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJW, .
14.
Wijnen J. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 704-714.
15.
Heiskanen I, Kellokumpu IH, Järvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999; 31: 412-416.
16.
Bülow S, Björk J, Christensen IJ, Fausa O, Järvinen H, Moesgaard F, Vasen HFA, DAF Study Group. Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004; 53: 381-386.
17.
Domizio P, Talbot IC, Spigelman AD, Williams CB, Phillips RK. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. J Clin Pathol 1990; 43: 738-743.
18.
Alarcon FJ, Burke CA, Church JM, van Stolk RU. Familial adenomatous polyposis. Dis Colon Rectum 1999; 42: 1533-1536.
19.
Syngal S, Brand RE, Church JM, Giardello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015; 110: 223-263.
20.
Wytyczne postępowania w polipowatości rodzinnej (FAP/AFAP/MAP). Uzgodnione stanowisko ekspertów – Wytyczne i artykuły przeglądowe – Gastrologia – Medycyna Praktyczna dla lekarzy. Accessed March 5, 2019. https://www.mp.pl/gastrologia/....
22.
Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363-369.
23.
Durno CA, Gallinger S. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastroenterol Nutr 2006; 43: 5-15.
24.
Sagar PM, Möslein G, Dozois RR. Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis: Dis Colon Rectum 1998; 41: 1350-1355.
25.
Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MWY, Lu KH, Roach N, Limburg PJ; American Society of Clinical Oncology; European Society of Clinical Oncology. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol 2015; 33: 209-217.
26.
Kozłowska M, Głuszek S. Współczesne metody leczenia raka odbytnicy. Med Stud 2015; 31: 307-312.
27.
Pierzak M, Głuszek S, Kozieł A, Wychowaniec M. Jakość życia chorych ze stomią jelitową wyłonioną w przebiegu leczenia raka odbytnicy i esicy. Med Stud 2016; 32: 37-44.
28.
Campos FG. Surgical treatment of familial adenomatous polyposis: dilemmas and current recommendations. World J Gastroenterol 2014; 20: 16620-16629.
29.
Bülow C, Vasen H, Järvinen H, Björk J, Bisgaard ML, Bülow S. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology 2000; 119: 1454-1460.
30.
Heiskanen I, Järvinen HJ. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis 1997; 12: 9-13.
31.
Vasen H, van der Luijt R, Slors J, Buskens E, de Ruiter P, Baeten CG, Schouten WR, Oostvogel HJ, Kuijpers JH, Tops CM, Meera Khan P. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996; 348: 433-435.
32.
Ng KS, Gonsalves SJ, Sagar PM. Ileal-anal pouches: a review of its history, indications, and complications. World J Gastroenterol 2019; 25: 4320-4342.
33.
Nilubol N, Scherl E, Bub DS, Gorfine SR, Marion J, Harris MT, Kornbluth A, Lichtiger S, Rubin P, George J, Chapman M, Harpaz N, Present D, Bauer JJ. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum 2007; 50: 825-831.
34.
Tajika M, Tanaka T, Ishihara M, Hirayama Y, Oonishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Ooshiro T, Kinoshita T, Komori K, Bhatia V, Hara K, Yatabe Y, Niwa Y. Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis. Endosc Int Open 2019; 7: E691-E698.
35.
Aziz O, Athanasiou T, Fazio VW, Nicholls RJ, Darzi AW, Church J, Phillips RKS, Tekkis PP. Meta-analysis of observational studies of ileorectalversus ileal pouch–anal anastomosis for familial adenomatous polyposis. Br J Surg 2006; 93: 407-417.
36.
Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, Visa J. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002; 359: 2224-2229.
37.
Krokowicz P. Management of familial polyposis in Poland. In: Hereditary Colorectal Cancer. Utsunomiya J, Lynch HT (eds.). Springer, Japan 1990; 71-74.
38.
King JE, Dozois RR, Lindor NM, Ahlquist DA. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000; 75: 57-67.
39.
Saha D, Roman C, Beauchamp RD. New strategies for colorectal cancer prevention and treatment. World J Surg 2002; 26: 762-766.
40.
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-639.
41.
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-1316.
43.
Burke CA, Dekker E, Samadder NJ, Stoffel E, Cohen A. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, phase III trial. BMC Gastroenterol 2016; 16: 87-87.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
